Glycan Analysis Podcast - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Glycan Analysis Podcast

Pharmaceutical Technology


Welcome to the Basic Training series, providing tutorials, best practices, and podcasts about how to take a product from discovery to development. The series features articles, interviews, and expertise from the global biotechnology industry about bioprocessing with NIBRT, business strategies and models, and technical solutions.

This Podcast was brought to you by



In BioPharm's Basic Training series, experts from the National Institute for Bioprocess Research and Training (NIBRT) provide in-depth looks at key bioprocessing steps.

Downstream Processing: A Primer
NIBRT's Ian Nelligan on what to expect when starting a downstream process. Posted Oct. 2012.

Upstream Processing: A Primer
NIBRT's Ian Nelligan on on what to expect when starting an upstream process, including the choice between single-use and stainless-steel bioreactors. Posted Sept. 2012.

NIBRT's Ray O'Connor on Aseptic Processing
Ray O'Connor, an operations consultant with NIBRT, addresses aseptic processing, including how to avoid contamination and cleanroom best practices. Posted May 2012.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here